Hook / Thesis
Roper Technologies is a classic software-and-industrial roll-up playing to multiple 2026 secular themes: enterprise cloud migration (notably Deltek), targeted AI agents embedded into vertical workflows, and ongoing disciplined M&A. The combination of sticky SaaS economics (retention in the mid-90s), continued organic growth and roughly $6 billion+ of acquisition capacity gives management options to accelerate growth without overpaying.
Q3 results released on 10/22/2026 reinforced that thesis: adjusted EPS of $5.89 beat expectations, organic revenue growth of 7%, and management raised full-year adjusted EPS guidance to $22.35 - $22.40 while expecting revenue growth above 8%. With the stock trading at about $434.45 and a P/E near 17x, we see a defined long trade with a clear stop and target.
What Roper Does and Why the Market Should Care
Roper is a diversified technology company operating three segments: Application Software, Network Software and Technology Enabled Products. Its Application Software group — which includes Deltek, Vertafore and Frontline Education — benefits from high retention and predictable recurring revenue. Network Software includes logistics and marketplace businesses such as DAT and Loadlink. Technology Enabled Products covers niche engineered products including medical devices and industrial sensors.
Investors should care because Roper combines durable recurring revenue (high retention), secular tailwinds (cloud migration and AI agents applied to vertical workflows), and a conservative balance sheet that supports bolt-on M&A. That trifecta can sustain mid-to-high single-digit organic growth while M&A and productivity improvements lift overall revenue and margin trajectory.
Quarterly Proof Points (numbers)
- Q3 adjusted EPS: $5.89 (15% YoY growth and 1.7% beat).
- Organic revenue growth: 7% (company expects revenue growth above 8% for fiscal 2026).
- Free cash flow: $2.622B (most recent reported figure) - strong cash generation relative to market cap.
- Market cap roughly $42.97B and enterprise value about $53.92B.
- Valuation multiples: P/E ~17x, EV/EBITDA ~19.3x, price-to-sales ~5.19x.
- Leverage: debt-to-equity ~0.61x, giving the company room for acquisition financing.
Valuation framing
At a market cap around $42.97B and P/E of roughly 17x on expected 2026 adjusted EPS near the raised guidance midpoint (~$22.375), the stock is not priced for hypergrowth — it reflects steady, predictable growth with some premium for high-quality software assets and strong cash flow. EV/EBITDA of ~19.3x implies the market already values margin expansion and steady M&A contribution, but it leaves room for upside if cloud migrations accelerate or acquisitions add immediate accretion.
Put simply: you are paying a moderate multiple for high-quality recurring revenue and excellent free cash flow generation (~$2.62B). If Roper converts Deltek customers to cloud subscriptions faster than expectations or completes accretive deals from its $6B+ capacity, multiples should expand or earnings will grow into the valuation.
Trade Plan (actionable)
- Direction: Long ROP.
- Entry price: 434.45
- Target price: 480.00
- Stop loss: 390.00
- Horizon: long term (180 trading days) - we expect the cloud migration cadence, incremental AI rollouts and at least one bolt-on acquisition outcome to play out across a multi-month window.
Rationale: entry near current price captures recent pullback from the 52-week high of $464.98. The target at $480 is achievable if the business sustains organic growth above 7-8% and management executes M&A or accelerates Deltek cloud migrations. The stop at $390 protects capital if macro stress or a material slowdown in bookings undermines the recurring revenue story.
Catalysts to drive gains
- Faster Deltek cloud migration and evidence of customers converting to higher-priced cloud/subscription models (meaningful ARR re-rating).
- Progress on AI agent rollouts into vertical workflows that show measurable productivity or retention benefits; early case studies could shift investor sentiment.
- Disciplined M&A: one or more bolt-on acquisitions that use available balance-sheet capacity (~$6B+ cited by management) to add scale and cross-sell opportunities.
- Continued margin expansion and steady free cash flow (the company reported ~$2.622B FCF recently), which supports buybacks and shareholder returns.
Risks and counterarguments
- Macro slowdown / bookings risk: Software spending tends to be cyclical. A broad enterprise IT pullback could pressure new bookings and slow cloud migrations, hurting near-term revenue and EPS momentum.
- Execution on Deltek migration: Cloud migrations can be multi-year initiatives. If migrations take longer or produce lower-than-expected upsell, the near-term revenue/margin payoff could be delayed.
- M&A missteps: Roper has capacity to do deals, but overpaying or buying businesses that fail to integrate would damage returns and could increase leverage above comfortable levels.
- Valuation compression if margins miss: With EV/EBITDA near 19.3x, a disappointment on margin expansion or FCF could trigger multiple contraction and downside beyond the stop.
- Technical overbought / short squeeze dynamics: The RSI near 74.7 and elevated net short activity (days to cover ~7 days in mid-October) can create volatility; sharp moves higher or lower could accelerate price action unpredictably.
Counterargument: skeptics will note that much of Roper's growth has historically come from M&A rather than organic acceleration. If the acquisition environment tightens or management becomes cautious, the stock could languish at current multiples. That said, Roper's free cash flow and conservative leverage give it flexibility to pivot between buybacks, dividends and selective deals - a practical hedge against the pure-M&A dependency argument.
What would change our view
We would downgrade the trade if any of the following occur: a clear slowdown in Deltek cloud conversion metrics, a sizable acquisition that meaningfully increases leverage without clear path to accretion, or guidance that meaningfully backtracks revenue growth below the mid-single digit range. Conversely, quicker-than-expected ARR conversion at Deltek, visible near-term benefits from AI agent rollouts, or an accretive acquisition would cause us to add to the position and raise our target.
Quick reference table - key metrics
| Metric | Value |
|---|---|
| Current price | $434.45 |
| Market cap | $42.97B |
| P/E | ~17x |
| EV/EBITDA | ~19.3x |
| Free cash flow | $2.622B |
| Debt / Equity | ~0.61x |
Final thoughts
Roper sits at the intersection of recurring revenue durability, AI-inflected product upgrades, and the optionality of disciplined M&A. The Q3 results and guidance raise the probability that the company keeps growing without sacrificing margins. A long entry at $434.45 with a stop at $390 and target of $480 provides a sensible, capital-efficient trade for investors willing to wait the long term (180 trading days) for operational catalysts and M&A outcomes to materialize.
Key dates
- Q3 results: 10/22/2026 (reported EPS beat and raised guidance)
- Recent analyst commentary and upgrade: coverage and positive notes published around 10/19 - 10/26/2026
Trade checklist: Enter at $434.45, stop $390, target $480, hold through the long term (180 trading days) and reassess on material updates to Deltek migration cadence or M&A outcomes.